Biomea Fusion, Inc. (BMEA) intrinsic value & 10-year financials
Biomea Fusion, Inc. (BMEA) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.87
- Market cap
- $45.4M
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -19502.4%
- Free cash flow (FY2025)
- —
BMEA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$61.8M | -$1.18 | — | — | 638.8% |
| FY2024 | — | -$138.4M | -$3.83 | -$120.3M | — | -154085.6% |
| FY2023 | — | -$117.3M | -$3.44 | -$100.0M | — | 16908.2% |
| FY2022 | — | -$81.8M | -$2.80 | -$63.4M | — | -497.2% |
| FY2021 | — | -$41.6M | -$1.74 | -$38.6M | — | -117.9% |
| FY2020 | — | -$5.3M | -$0.51 | -$4.5M | — | -207.0% |
| FY2019 | — | -$1.2M | — | — | — | 843.7% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Biomea Fusion, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Biomea Fusion, Inc. has historically struggled to out-earn its cost of capital, averaging just -297.7% ROIC.
Biomea Fusion, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Biomea Fusion, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.